https://matjournals.net/pharmacy/index.php/JCTR/issue/feed Journal of Clinical Trials and Regulations (e-ISSN: 2582-4422) 2025-12-18T09:48:03+00:00 Open Journal Systems <p><strong>JCTR</strong> is a peer-reviewed academic journal which embraces articles related to Clinical Trials and Regulations. The journal with a wide scope in the arena of pharmaceutical sciences covers the topics intended to be of interest to a broad audience of pharmaceutical professionals and ideally placed to serve the needs of their readers. The focuses of the journal are ICH/GCP, DMF and Dossier, Clinical Research, Pharmacovigilance, USDFA/EU, EU Clinical Trial developments, Manufacturing, Quality Control, GCP, ICH, Ethics, IRB, Regulations for Clinical Trials, Clinical Trials Data Management.</p> https://matjournals.net/pharmacy/index.php/JCTR/article/view/222 Hypochondria 2025-08-04T05:38:57+00:00 Ravina Rani goyalraveena7@gmail.com <p><em>Hypochondria are a psychological disorder characterized by excessive thoughts about having a serious illness in the absence of adequate medical evidence. Patients tend to misinterpret normal bodily sensations or small symptoms as indications of a serious disease, triggering significant anxiety and distress. The article publishes an exhaustive study of hypochondria, treating its symptoms, causes, impacts, and treatment possibilities. It starts with the symptoms of hypochondria since the discord er is characterized by excessive health-related anxiety, repeated self-examinations, persistent fears about ill health, and avoidance of medical environments. It is further emphasized that these symptoms must be differentiated from others in distinct medical conditions. The article then examines all contributing factors to hypochondria, such as genetic predisposition, traumatic health experiences, psychological factors (e.g., stress and anxiety), and cognitive misinterpretations of bodily sensations. These overlapping factors result in further development and the even continued presence of health anxiety within an individual. The article then makes two types of hypochondria - health anxiety without important physical symptoms and health anxiety with mild physical symptoms - further stressing the pertinence of recognizing these types for correct diagnosis and treatment. In addition, the article talks about the aspect that highlights the positive effect of hypochondria on patient care and mental health support systems. It presents the outline of the diagnostic process, which comprises clinical evaluation, reviewing the medical history, and ruling out other health conditions. The role of Cognitive Behaviour Therapy (CBT) in hypochondria treatment is also discussed in the article; it explains the techniques and also the efficacy of such treatment in hypochondria cases. The article also focuses on the severity of health anxiety as well as the different facets where it touches on one's daily living, emotional being, and relationships. In short, the article emphasizes the importance of improving the quality of life of hypochondriacs through recognition, diagnosis, and treatment. It calls for a comprehensive support and interventional resource mobilization in the management of hypochondria.</em></p> 2025-08-04T00:00:00+00:00 Copyright (c) 2025 Journal of Clinical Trials and Regulations (e-ISSN: 2582-4422) https://matjournals.net/pharmacy/index.php/JCTR/article/view/246 Seasonality and Subnational Heterogeneity of Dengue in Bangladesh: A Descriptive Epidemiology 2025-11-19T08:20:49+00:00 Md Raiyan Hashar raiyan.hsr@eco-sphere.org Rehnuma Abdullah raiyan.hsr@eco-sphere.org Shahnoor Shabab raiyan.hsr@eco-sphere.org Md. Mahmudur Rahman Chowdhury raiyan.hsr@eco-sphere.org Syeda Saberin Jahan raiyan.hsr@eco-sphere.org <p><em>Dengue imposes a substantial and shifting hospital burden in Bangladesh. Subnational, setting- and sex-specific profiles can support surge planning and targeted control. A retrospective, cross-sectional analysis of routine aggregates from the Directorate General of Health Services (DGHS), Bangladesh dengue dashboard was conducted for 2024. We computed national totals and admission-based fatality (deaths ÷ admissions × 100), and profiled divisions, city-corporation versus outside-city settings, sex, and month-wise seasonality. In 2024, there were 101,211 admissions, 575 deaths, and 100,040 discharges, yielding an in-hospital fatality of 0.57%. Divisionally, Dhaka accounted for 57% of admissions and 69% of deaths; Barishal for 8.7% of admissions and 11.1% of deaths; Chattogram for 15.3% of admissions and 9.6% of deaths; Khulna for 9.9% of admissions and 6.1% of deaths; Sylhet recorded 0 deaths with few cases. Admission-based fatality was highest in Barishal (0.73%), followed by Dhaka (0.68%) and Mymensingh (0.48%). Within-division setting patterns diverged: in Dhaka, ≈68% of admissions and ≈87% of deaths occurred inside the city-corporation, whereas in Chattogram the city-corporation contributed &lt;2% of division totals for both admissions and deaths. By sex, males were 63% of admissions, with fatality 0.4% in males versus 0.8% in females (overall 0.6%). Seasonality showed rising admissions and deaths from July, peaks in October–November, and a decline in December; the first quarter displayed a relatively higher death-to-admission proportion. Historical context showed a COVID-era dip in 2020 (1,405 admissions) and a peak in 2023 (321,017). Bangladesh’s 2024 dengue burden is highly concentrated in Dhaka, with notable excess fatality shares in Barishal and a strong urban skew in the Dhaka city-corporation. Sex and seasonal differences, higher female fatality among admissions and early-year proportional fatality highlight the need for risk-based triage, timely referral, and targeted vector control aligned with predictable peaks.</em></p> <p><em>&nbsp;</em></p> 2025-11-19T00:00:00+00:00 Copyright (c) 2025 Journal of Clinical Trials and Regulations (e-ISSN: 2582-4422) https://matjournals.net/pharmacy/index.php/JCTR/article/view/248 Vancomycin’s Red Flag: A Review of Red Man Syndrome 2025-11-25T11:00:09+00:00 Tamil Mozhi R rameshprofdr@gmail.com Ramesh K rameshprofdr@gmail.com Swathi G raiyan.hsr@eco-sphere.org Nepolean R raiyan.hsr@eco-sphere.org <p><em>Vancomycin-induced Red Man Syndrome (RMS) is a common adverse drug reaction characterized by non-IgE mediated histamine release, resulting from the rapid intravenous infusion of vancomycin. Unlike a true allergic reaction, RMS is a direct pharmacological effect that can cause significant patient discomfort and lead to unnecessary treatment interruptions. The clinical presentation typically includes flushing and erythema of the face, neck, and upper torso, along with pruritus, urticaria, and, in more severe cases, angioedema and hypotension. The primary management strategy involves immediately stopping the infusion and administering antihistamines. Prevention is paramount, with the most effective measures being slowing the infusion rate to a minimum of 60 minutes per gram and, for high-risk patients, premedication with H1 and H2 blockers. Understanding the distinct mechanism and implementing proper preventive protocols are crucial for healthcare professionals to ensure the safe and effective administration of vancomycin.</em></p> 2025-11-25T00:00:00+00:00 Copyright (c) 2025 Journal of Clinical Trials and Regulations (e-ISSN: 2582-4422) https://matjournals.net/pharmacy/index.php/JCTR/article/view/262 A Recent Review on Integration of Artificial Intelligence in Cardiovascular Medicine: Advancing Diagnosis, Pathophysiology, and Personalized Therapeutics 2025-12-09T10:22:03+00:00 Nidhi Sharma dmnankush94@gmail.com Ankush Dhiman dmnankush94@gmail.com Simran Kaur dmnankush94@gmail.com Shubham Kumar dmnankush94@gmail.com <p><em>The medical field has adopted Artificial Intelligence (AI), which is the process of using advanced computer algorithms to extract information from complex databases. AI techniques have shown that they can speed up the process of diagnosing and treating cardiovascular diseases (CVDs), such as heart malfunction, atrial fibrillation, heart valve disorder, hypertrophic cardiomyopathy, also known as congenital heart disease, and more. In real-life situations, AI has been shown to work well for diagnosing CVD, making auxiliary tools more useful, classifying and typing diseases, and predicting outcomes. Advanced algorithms for artificial intelligence are expected to be able to handle even more complicated assignments than traditional methods because they are very well developed to find subtle ties in huge amounts of healthcare data. This review aims to present contemporary ways to utilize AI in cardiovascular diseases (CVDs), facilitating clinicians with limited computer science expertise to comprehend the forefront of the field and implement AI algorithms in clinical practice.</em></p> 2025-12-09T00:00:00+00:00 Copyright (c) 2025 Journal of Clinical Trials and Regulations (e-ISSN: 2582-4422) https://matjournals.net/pharmacy/index.php/JCTR/article/view/268 Revealing Health Literacy: An Inquiry into Public Comprehension of Medication Labels, Instructions, and Dosage Regimens 2025-12-18T09:48:03+00:00 Ramya C.V ramyaramcv@gmail.com Zaid Khan ramyaramcv@gmail.com Mekkanti Manasa Rekha ramyaramcv@gmail.com <p><strong><em>Background</em></strong><em>: Health literacy plays a crucial role in ensuring medication safety and informed decision-making. Understanding the factors that influence individuals’ ability and willingness to seek medication-related information is essential for improving public health outcomes.</em></p> <p><strong><em>Aim:</em></strong><em> To assess the relationship between demographic characteristics, label-reading behaviors, comfort in interpreting medication information, and the likelihood of seeking additional health information.</em></p> <p><strong><em>Methods:</em></strong><em> A cross-sectional analysis was conducted using responses from 150 adults. Variables included age, gender, education level, socioeconomic status, location, frequency of reading medication labels, comfort reading labels, and information-seeking behaviour. Chi square </em><em>Goodness-of-Fit Test for Demographic Variables</em><em>, Spearman’s correlation assessed associations between health-literacy behaviors, while binary logistic regression identified independent predictors of seeking additional information.</em></p> <p><strong><em>Results: </em></strong><em>Chi-square goodness-of-fit tests showed no significant deviations across gender, age, income, or education distributions, indicating that all demographic variables were evenly represented in the sample. Correlation analysis showed no significant relationships between age (ρ = –0.021), education (ρ = 0.062), reading frequency (ρ = 0.074), comfort reading labels (ρ = 0.043), or other variables and information-seeking behavior (all p &gt; 0.05). Binary logistic regression revealed no significant predictors, with none of the demographic or behavioral factors demonstrating a statistically meaningful association with seeking additional medication information (p &gt; 0.05). The model’s predictive power was low (pseudo R² = 0.027).</em></p> <p><strong><em>Conclusion: </em></strong><em>Information-seeking behavior—an important marker of functional health literacy—is not determined solely by demographic characteristics or basic label-reading behaviors. Health literacy appears to be influenced by broader psychosocial, motivational, and contextual factors. Targeted, multidimensional interventions are needed to enhance medication comprehension and promote informed health decisions across diverse populations.</em></p> 2025-12-18T00:00:00+00:00 Copyright (c) 2025 Journal of Clinical Trials and Regulations (e-ISSN: 2582-4422)